The CCRA Board Welcomes Dr. Don Desserud
Effective January 1, 2020, Dr. Don Desserud begins his term as the Patient/Family Representative on the CCRA Board. Dr. Desserud participated in the 2019 Patient Involvement in Cancer Research Project (PIP) and is a survivor of Non-Hodgkin Lymphoma.
Dr. Desserud is a Political Science professor and researcher at the University of Prince Edward Island. He is very familiar with peer review and the research funding landscape in Canada. He also serves on three other boards: the Quality Assurance Committee at the Canadian Partnership Against Cancer, Health PEI’s Cancer Strategy Coordination Committee, and the PEI Electronic Synoptic Pathology Reporting Initiative (ESPRI) Committee.
We welcome Dr. Desserud and look forward to the contribution he will make to the CCRA going forward.
Story Visualizations Released
As companions to our 2016 special topic reports, CCRA has released interactive 'story visualizations' using Tableau software. Story visualizations are dashboards that are linked sequentially. They walk users through a series of analyses, each with greater detail, and allowing users more opportunity to ‘interact’ with ... Read More »
As companions to our 2016 special topic reports, CCRA has released interactive 'story visualizations' using Tableau software. Story visualizations are dashboards that are linked sequentially. They walk users through a series of analyses, each with greater detail, and allowing users more opportunity to ‘interact’ with ... Read More »
Call for Operating Grant Proposals from LLSC
Canadian researchers are invited to submit proposals to The Leukemia & Lymphoma Society of Canada’s (LLSC) Operating Grant program for research aimed at preventing, detecting and treating all types of blood cancers. The application process consists of two phases. The first phase is submission and consideration of a Lette... Read More »
Canadian researchers are invited to submit proposals to The Leukemia & Lymphoma Society of Canada’s (LLSC) Operating Grant program for research aimed at preventing, detecting and treating all types of blood cancers. The application process consists of two phases. The first phase is submission and consideration of a Lette... Read More »